Why is Ipca Labs falling/rising?

As of 11-Jul, Ipca Laboratories Ltd is experiencing a decline in its stock price, currently at 1,448.60, reflecting a decrease of 2.4 points or 0.17%. The stock has underperformed its sector by 0.75% today and has been on a consecutive downward trend for the last three days, resulting in a total decline of 1.19% during this period. Despite showing positive returns over the past year at 18.54%, which significantly outpaces the market's return of 3.26%, the stock's year-to-date performance is notably poor, with a decline of 14.37%. Additionally, the stock's delivery volume has decreased by 35.41% compared to the 5-day average, indicating falling investor participation.
In the broader market context, while the stock has shown a positive return of 2.10% over the past week, the benchmark Sensex has declined by 1.12% in the same timeframe, suggesting that the stock's recent performance is relatively strong compared to the market. However, the stock's liquidity remains adequate for trading, and its low debt-to-equity ratio, along with positive quarterly results and high institutional holdings, suggests a stable financial position. Despite these strengths, the recent price movement reflects investor caution, possibly due to the stock's consecutive declines and reduced trading activity.